title: Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia.
authors.forename: P
authors.initials: P
authors.lastname: Blanche
authors.forename: D
authors.initials: D
authors.lastname: Bouscary
authors.forename: B
authors.initials: B
authors.lastname: Gombert
authors.forename: N
authors.initials: N
authors.lastname: Stieltjes
authors.forename: F
authors.initials: F
authors.lastname: Dreyfus
authors.forename: D
authors.initials: D
authors.lastname: Sicard
mesh_terms: D000368:Aged; D000906:Antibodies / Q000276:immunology*; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005169:Factor VIII / Q000009:adverse effects* / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000906:Antibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D005169:Factor VIII; D014740:Vidarabine; C024352:fludarabine